Delivery Order SPE2DB22D1106-SPE2DB24FEFC1
Award Date
3/15/24
Potential Completion Date
3/18/24
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,115.50 fixed-price contract is for the supply of 120 tablets of the medication Capecitabine 500 mg. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $1,409.52 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide 120 tablets of 500 mg Capecitabine, a chemotherapy medication. The contract has a completion date of March 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the...
This federal contract award, valued at $1,176.90, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of 4554804687 - Capecitabine 500 mg Tablets 120s, a prescription medication. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
This federal contract award, with ID SPE2DB20D7061|SPE2DB24FSPQ7, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The $1,592.32 firm-fixed-price delivery order is for the supply of 4565606290 Capecitabine 500 mg tablets. The contract has an ultimate completion date of August 29, 2024 and was awarded on August 28, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of CAPECITABINE 500 MG TABLET 120S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,278.51 and a completion date of May 13, 2024. It is a delivery order contract with a firm fixed price pricing type. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The $1,761.90 award is for the supply of 4563170212 - CAPECITABINE 500 MG TABLET 120S, a pharmaceutical product, with a completion date of December 26, 2023. No set-aside designations were used. Amerisourcebergen Drug Corp has previously received numerous DLA contract awards...
The Defense Logistics Agency awarded a delivery order under an indefinite-delivery/indefinite-quantity contract vehicle to Amerisourcebergen Drug Corporation. The firm fixed price order, valued at approximately $921, is for the delivery of 60 tablets of Xeloda 150 mg to a facility in Conshohocken, Pennsylvania. Performance is required from August 25 to August 28, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense globally, this order supports the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the cancer medication Cabometyx 40 mg tablets. The contract has a ceiling value of $15,346.55 and a performance period through May 27, 2025. It is a firm-fixed-price contract, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription medication Cabometyx 60 mg tablets. The contract has a ceiling value of $30,602.10 and a period of performance through May 29, 2025. It is a firm fixed-price, non-set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $30,693.10, is for the delivery of 4,567,984,745 units of the medication CABOMETYX 40 MG TABLET 30S. The contract is a firm fixed-price delivery order without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...